- IGM Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- IGM Biosciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- IGM Biosciences Inc Clinical Update Conference Call TranscriptJun 02, 2023
- IGM Biosciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- IGM Biosciences Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 26, 2023
- Q4 2022 IGM Biosciences Inc Earnings Call TranscriptMar 30, 2023$17.02 (-1.45%)Earnings
- IGM Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- IGM Biosciences Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- IGM Biosciences Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- IGM Biosciences Inc to Discuss Global Collaboration Agreement with Sanofi - Conference Call TranscriptMar 29, 2022
- IGM Biosciences Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- IGM Biosciences Inc to Discuss IGMS ASH Data - Conference Call TranscriptDec 12, 2021
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- IGM Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- IGM Biosciences Inc at Truist Securities Life Sciences Summit (May Series) TranscriptMay 04, 2021
- Q4 2020 IGM Biosciences Inc Earnings Call TranscriptMar 30, 2021$75.06 (+1.86%)Earnings
- IGM Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Medivir AB to Discuss Exclusive Licensing Agreement with IGM Biosciences for Birinapant Call TranscriptJan 12, 2021
- IGM Biosciences Inc Review of IGM-2323 Data Presented at the 62nd Annual ASH Meeting - Conference Call TranscriptDec 05, 2020
- IGM Biosciences Inc at Wolfe Research Healthcare Conference (Virtual) TranscriptNov 18, 2020
- IGM Biosciences Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- IGM Biosciences Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- IGM Biosciences Inc Extraordinary Shareholders Meeting TranscriptJul 30, 2020
- IGM Biosciences Inc Annual Shareholders Meeting TranscriptJun 09, 2020
- Q4 2019 IGM Biosciences Inc Earnings Call TranscriptMar 26, 2020$43 (-9.11%)Earnings
- IGM Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
Q4 2020 IGM Biosciences Inc Earnings Call Transcript
Good day, everyone, and welcome to the IGM Biosciences Fourth Quarter and Full Year 2020 Financial Results Call. Today's call is being recorded. At this time, I'd like to turn the call over to Misbah Tahir, Chief Financial Officer of IGM.
Thank you, operator. Welcome, and thank you to those of you joining us today to discuss IGM's fourth quarter and full year 2020 financial results. With me this afternoon to discuss the financial results and to provide a general corporate update are Fred Schwarzer, Chief Executive Officer; Bruce Keyt, Chief Scientific Officer; Dan Chen, Chief Medical Officer; and Lisa Decker, Chief Business Officer.
Please note that we will be making forward-looking statements on this call, including statements about IGM's plans, expectations and forecasts and about future events. Actual results may differ materially as a result of various risks and uncertainties, including those discussed in the company's most recent annual report on Form 10-K as well as its other filings with the SEC. Any
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)